Polymedco
Manufacturer and distributor of diagnostic screening and point-of-care testing solutions focused on early detection programs for colorectal cancer and urgent cardiac conditions. Offers automated and manual immunochemical stool tests, point-of-care cardiac biomarker analyzers, automated ESR systems, quality-control programs, and programmatic implementation and education resources for health systems, laboratories, and direct-to-patient screening.
Industries
Nr. of Employees
medium (51-250)
Products
Manual fecal immunochemical lateral-flow test (single-sample)
Analyzer-free lateral-flow fecal immunochemical test for detection of human hemoglobin in stool, designed for professional or at-home collection with rapid visual read in minutes; room-temperature sample stability for return logistics.
Automated fecal immunochemical analyzer systems
Automated analyzers for quantitative/qualitative fecal immunochemical testing with barcode readers, closed sampling bottles, QC/calibration support, and high hourly throughput for laboratory screening programs.
Point-of-care cardiac biomarker analyzer (benchtop CLEIA)
Benchtop point-of-care analyzer delivering chemiluminescence immunoassay results for multiple cardiac biomarkers from whole blood or plasma in under ~17 minutes with LIS connectivity and multi-test throughput.
Automated ESR readers
Automated erythrocyte sedimentation rate instruments that provide semi-quantitative ESR results with short read times (e.g., ~10–15 minutes) for clinical laboratories.
Rapid bladder cancer detection test (stat)
Rapid diagnostic assay intended for detection of recurrent bladder cancer with short turnaround time suitable for point-of-care or clinic use.
Manual fecal immunochemical lateral-flow test (single-sample)
Analyzer-free lateral-flow fecal immunochemical test for detection of human hemoglobin in stool, designed for professional or at-home collection with rapid visual read in minutes; room-temperature sample stability for return logistics.
Automated fecal immunochemical analyzer systems
Automated analyzers for quantitative/qualitative fecal immunochemical testing with barcode readers, closed sampling bottles, QC/calibration support, and high hourly throughput for laboratory screening programs.
Point-of-care cardiac biomarker analyzer (benchtop CLEIA)
Benchtop point-of-care analyzer delivering chemiluminescence immunoassay results for multiple cardiac biomarkers from whole blood or plasma in under ~17 minutes with LIS connectivity and multi-test throughput.
Automated ESR readers
Automated erythrocyte sedimentation rate instruments that provide semi-quantitative ESR results with short read times (e.g., ~10–15 minutes) for clinical laboratories.
Rapid bladder cancer detection test (stat)
Rapid diagnostic assay intended for detection of recurrent bladder cancer with short turnaround time suitable for point-of-care or clinic use.
Services
Customizable screening program design, patient outreach materials, and programmatic services to increase screening participation and optimize follow-up workflows.
Implementation support, in-service trainings, educational webinars, and resource center materials for integrating point-of-care assays into clinical workflows.
Web-based QC submission, monthly peer reporting, flags interpretation, and administrative user management for laboratory QC benchmarking.
Assistance with laboratory information system connectivity, standard data transfer protocols, and configuration guidance for analyzers.
Customizable screening program design, patient outreach materials, and programmatic services to increase screening participation and optimize follow-up workflows.
Implementation support, in-service trainings, educational webinars, and resource center materials for integrating point-of-care assays into clinical workflows.
Web-based QC submission, monthly peer reporting, flags interpretation, and administrative user management for laboratory QC benchmarking.
Assistance with laboratory information system connectivity, standard data transfer protocols, and configuration guidance for analyzers.
Expertise Areas
- Colorectal cancer screening program implementation
- Point-of-care cardiac biomarker testing
- Diagnostic assay development and analytical validation
- LIS integration and laboratory data workflows
Key Technologies
- Lateral-flow immunoassay (qualitative FIT)
- Chemiluminescence enzyme immunoassay (CLEIA)
- Magnetic-particle sample processing
- Latex agglutination immunoassay
News & Updates
Company announcement describing published research supporting the clinical and cost-effectiveness of fecal immunochemical testing for colorectal cancer screening.
Announcement of US FDA clearance for a high-sensitivity cardiac troponin I test intended to aid diagnosis of myocardial infarction.
Announcement of a partnership to participate in a collaborative effort to accelerate innovation in cancer detection and diagnosis.
Company announcement describing published research supporting the clinical and cost-effectiveness of fecal immunochemical testing for colorectal cancer screening.
Announcement of US FDA clearance for a high-sensitivity cardiac troponin I test intended to aid diagnosis of myocardial infarction.
Announcement of a partnership to participate in a collaborative effort to accelerate innovation in cancer detection and diagnosis.